311 related articles for article (PubMed ID: 21117032)
1. Pathogenic role of TGF-β in the progression of podocyte diseases.
Lee HS
Histol Histopathol; 2011 Jan; 26(1):107-16. PubMed ID: 21117032
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms and consequences of TGF-ß overexpression by podocytes in progressive podocyte disease.
Lee HS
Cell Tissue Res; 2012 Jan; 347(1):129-40. PubMed ID: 21541658
[TBL] [Abstract][Full Text] [Related]
3. Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy.
Ziyadeh FN; Wolf G
Curr Diabetes Rev; 2008 Feb; 4(1):39-45. PubMed ID: 18220694
[TBL] [Abstract][Full Text] [Related]
4. Paracrine role for TGF-β-induced CTGF and VEGF in mesangial matrix expansion in progressive glomerular disease.
Lee HS
Histol Histopathol; 2012 Sep; 27(9):1131-41. PubMed ID: 22806900
[TBL] [Abstract][Full Text] [Related]
5. Effects of TGF-beta on podocyte growth and disease progression in proliferative podocytopathies.
Lee HS; Song CY
Kidney Blood Press Res; 2010; 33(1):24-9. PubMed ID: 20185928
[TBL] [Abstract][Full Text] [Related]
6. [The role of podocyte injury in chronic kidney disease].
Asanuma K
Nihon Rinsho Meneki Gakkai Kaishi; 2015; 38(1):26-36. PubMed ID: 25765686
[TBL] [Abstract][Full Text] [Related]
7. The podocyte's response to injury: role in proteinuria and glomerulosclerosis.
Shankland SJ
Kidney Int; 2006 Jun; 69(12):2131-47. PubMed ID: 16688120
[TBL] [Abstract][Full Text] [Related]
8. Pathogenesis of nonimmune glomerulopathies.
Kwoh C; Shannon MB; Miner JH; Shaw A
Annu Rev Pathol; 2006; 1():349-74. PubMed ID: 18039119
[TBL] [Abstract][Full Text] [Related]
9. From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy.
Wolf G; Chen S; Ziyadeh FN
Diabetes; 2005 Jun; 54(6):1626-34. PubMed ID: 15919782
[TBL] [Abstract][Full Text] [Related]
10. Endothelial mitochondrial oxidative stress determines podocyte depletion in segmental glomerulosclerosis.
Daehn I; Casalena G; Zhang T; Shi S; Fenninger F; Barasch N; Yu L; D'Agati V; Schlondorff D; Kriz W; Haraldsson B; Bottinger EP
J Clin Invest; 2014 Apr; 124(4):1608-21. PubMed ID: 24590287
[TBL] [Abstract][Full Text] [Related]
11. Response of Renal Podocytes to Excessive Hydrostatic Pressure: a Pathophysiologic Cascade in a Malignant Hypertension Model.
Abu Hamad R; Berman S; Hachmo Y; Stark M; Hasan F; Doenyas-Barak K; Efrati S
Kidney Blood Press Res; 2017; 42(6):1104-1118. PubMed ID: 29224013
[TBL] [Abstract][Full Text] [Related]
12. Insight on the pathogenesis of diabetic nephropathy from the study of podocyte and mesangial cell biology.
Gruden G; Perin PC; Camussi G
Curr Diabetes Rev; 2005 Feb; 1(1):27-40. PubMed ID: 18220580
[TBL] [Abstract][Full Text] [Related]
13. Podocyte injury and overexpression of vascular endothelial growth factor and transforming growth factor-beta 1 in adriamycin-induced nephropathy in rats.
Yang W; Wang J; Shi L; Yu L; Qian Y; Liu Y; Wang W; Cheng S
Cytokine; 2012 Aug; 59(2):370-6. PubMed ID: 22579701
[TBL] [Abstract][Full Text] [Related]
14. Rethinking glomerular basement membrane thickening in diabetic nephropathy: adaptive or pathogenic?
Marshall CB
Am J Physiol Renal Physiol; 2016 Nov; 311(5):F831-F843. PubMed ID: 27582102
[TBL] [Abstract][Full Text] [Related]
15. Role of angiotensin II in diabetic nephropathy.
Leehey DJ; Singh AK; Alavi N; Singh R
Kidney Int Suppl; 2000 Sep; 77():S93-8. PubMed ID: 10997697
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of VEGF-A in podocytes of adult mice causes glomerular disease.
Veron D; Reidy KJ; Bertuccio C; Teichman J; Villegas G; Jimenez J; Shen W; Kopp JB; Thomas DB; Tufro A
Kidney Int; 2010 Jun; 77(11):989-99. PubMed ID: 20375978
[TBL] [Abstract][Full Text] [Related]
17. Differential role of mesangial cells and podocytes in TGF-beta-induced mesangial matrix synthesis in chronic glomerular disease.
Lee HS; Song CY
Histol Histopathol; 2009 Jul; 24(7):901-8. PubMed ID: 19475536
[TBL] [Abstract][Full Text] [Related]
18. Diabetic kidney lesions of GIPRdn transgenic mice: podocyte hypertrophy and thickening of the GBM precede glomerular hypertrophy and glomerulosclerosis.
Herbach N; Schairer I; Blutke A; Kautz S; Siebert A; Göke B; Wolf E; Wanke R
Am J Physiol Renal Physiol; 2009 Apr; 296(4):F819-29. PubMed ID: 19211686
[TBL] [Abstract][Full Text] [Related]
19. GLUT1 regulation of the pro-sclerotic mediators of diabetic nephropathy.
Heilig CW; Deb DK; Abdul A; Riaz H; James LR; Salameh J; Nahman NS
Am J Nephrol; 2013; 38(1):39-49. PubMed ID: 23817135
[TBL] [Abstract][Full Text] [Related]
20. Cellular and molecular mechanisms of proteinuria in diabetic nephropathy.
Wolf G; Ziyadeh FN
Nephron Physiol; 2007; 106(2):p26-31. PubMed ID: 17570945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
